Tsfg, LLC Palatin Technologies Inc Transaction History

Tsfg, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$0.27 - $0.5 $0 - $0	0 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$0.37 - $0.54 $7,400 - $10,800	-20,000 Closed	0 $0
Q4 2020 Jan 20, 2021	BUY	$0.38 - $0.78 $7,600 - $15,600	20,000 New	20,000 $14,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $10.3M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

Stay updated on Tsfg, LLC with notifications on news.